Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation
May 1, 2015, 00:00
10.1016/j.jval.2015.03.762
https://www.valueinhealthjournal.com/article/S1098-3015(15)00819-0/fulltext
Title :
Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00819-0&doi=10.1016/j.jval.2015.03.762
First page :
A131
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
201